tradingkey.logo
搜尋

STAAR Surgical Co

STAA
添加自選
27.790USD
-0.360-1.28%
收盤 07/02, 13:00美東報價延遲15分鐘
1.38B總市值
虧損本益比TTM

關於 STAAR Surgical Co 公司

STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. The Company markets and sells its ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. Its EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company's newest offering, EVO Viva, has an extended depth of focus (EDoF) optic, which is designed to treat myopia with presbyopia (age-related loss of ability to focus). It also market and sell an ICL lens to treat hyperopia (farsightedness), called Visian ICL. It makes its ICL product offerings available in multiple models, powers and lengths, including some with toric ICL (TICL) versions to correct for astigmatism (blurred vision). The Company’s principal products are ICLs used in refractive surgery, including its EVO family of lenses.

STAAR Surgical Co簡介

公司代碼STAA
公司名稱STAAR Surgical Co
上市日期Feb 24, 1992
CEOFarrell (Stephen C)
員工數量1157
證券類型Ordinary Share
年結日Feb 24
公司地址1911 Walker Ave
城市MONROVIA
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編91016
電話16263037902
網址https://www.staar.com/
公司代碼STAA
上市日期Feb 24, 1992
CEOFarrell (Stephen C)

STAAR Surgical Co公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Stephen C. (Steve) Farrell, CPA
Mr. Stephen C. (Steve) Farrell, CPA
Chief Executive Officer, Director
Chief Executive Officer, Director
82.21K
+57.24%
Mr. Wei Jiang
Mr. Wei Jiang
Director
Director
78.19K
+13.66%
Mr. Warren Foust
Mr. Warren Foust
President, Chief Operating Officer
President, Chief Operating Officer
69.54K
+18.35%
Dr. Magda Michna, Ph.D.
Dr. Magda Michna, Ph.D.
Chief Development Officer
Chief Development Officer
33.42K
+25.17%
Mr. Nathaniel B. Sisitsky, Esq.
Mr. Nathaniel B. Sisitsky, Esq.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
30.18K
+72.87%
Ms. Deborah J. Andrews
Ms. Deborah J. Andrews
Chief Financial Officer
Chief Financial Officer
18.65K
+53.97%
Mr. Louis E. (Lou) Silverman
Mr. Louis E. (Lou) Silverman
Independent Director
Independent Director
11.16K
+95.74%
Dr. Elizabeth Yeu, M.D.
Dr. Elizabeth Yeu, M.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
5.10K
--
Mr. Brian Moore
Mr. Brian Moore
Vice President - Investor Relations and Corporate Development
Vice President - Investor Relations and Corporate Development
--
--
Ms. Lilian Zhou
Ms. Lilian Zhou
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Stephen C. (Steve) Farrell, CPA
Mr. Stephen C. (Steve) Farrell, CPA
Chief Executive Officer, Director
Chief Executive Officer, Director
82.21K
+57.24%
Mr. Wei Jiang
Mr. Wei Jiang
Director
Director
78.19K
+13.66%
Mr. Warren Foust
Mr. Warren Foust
President, Chief Operating Officer
President, Chief Operating Officer
69.54K
+18.35%
Dr. Magda Michna, Ph.D.
Dr. Magda Michna, Ph.D.
Chief Development Officer
Chief Development Officer
33.42K
+25.17%
Mr. Nathaniel B. Sisitsky, Esq.
Mr. Nathaniel B. Sisitsky, Esq.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
30.18K
+72.87%
Ms. Deborah J. Andrews
Ms. Deborah J. Andrews
Chief Financial Officer
Chief Financial Officer
18.65K
+53.97%

常見問題

STAAR Surgical Co的前五大股東是誰?

STAAR Surgical Co的前五大股東如下:Mr. Stephen C. (Steve) Farrell, CPA

有多少機構持有STAAR Surgical Co(STAA)的股份?

截至2026Q1,共有543家機構持有STAAR Surgical Co的股份,合計持有的股份價值約為58.06M,占公司總股份的116.62% 。與2025Q4相比,機構持股有所增加,增幅為-10575638.00。